Replies to post #116926 on Innovation Pharmaceuticals Inc (IPIX)

[Drano]

I wonder whose opinion I should value more, some guy on the internet who isn't very familiar with the company and seems to have an agenda, or should I believe the FDA, Dana-Farber Institute, other scientific institutions, and the evidence I can read and understand myself from the poster presentations at major scientific conferences?

That should answer any questions anyone had about the damning-with-faint-praise this guy published recently.

[nerby]

My word. The data in your linked article looks quite good. Stellar, in fact.

[maverick_1]

Wow: falling off another ledge: BB stks easy to manipulate most especially in this mkt environment.

Everyone should bookmark and digest this:
http://www.biotechpicklist.com/bioinvesting/

These excerpts applies when retail continues on overload and still on BB :

Manipulation – When you invest long term be prepared for complete manipulation of your stock. Regardless of your due diligence, and your patience there will be someone out there who will write a negative article while shorting the stock. Understand that this happens a lot in biotech stocks. These manipulators know how speculative these stocks are, and so they know that many investors will dump at the first sign of any negative article.

Risk of Biotech trading on OTC BB – (Over The Counter Bulletin Board) – Biotech stocks are risky as is, but when you add a new element it can get even riskier. So what is this new element that I speak of ? Well I’m talking about biotech stocks that trade on “Over the Counter Bulletin Board”. OTC BB is a lower level trading exchange, what makes this more risky is that stocks that trade on this exchange are more volatile. So what is so risky about this exchange? Let’s just say that there are more heavy short sellers and stock manipulators on here than one desires. What is the reason for this? Well OTC BB stocks have lower volume typically so that is a huge plus for heavy short sellers. They are able to easily manipulate the bid/ask price of a stock and play it like a fiddle. Another risky aspect is that most, not all biotechs, that trade on the OTC BB are behind on their SEC filings. The basic premise to learn here is that OTC stocks carry way more risks than higher level exchange stocks. For example big institutional investors like Fidelity, JPmorgan, Roth Capital, etc. aren’t allowed to buy OTC BB stocks. They also normally can’t buy stocks that trade below $5 sometimes. Just understand that there is heavy risk here. That doesn’t mean though to exclude it completely, because with due diligence you can find some diamonds that trade on the OTC BB exchange.

Glad I made the right decision on CTIX to take a modest loss selling@$4.20 last Dec 2014.